Stock Comparison
ARGX vs BNTX
argenx NV ADR and BioNTech SE side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$23.07B
P/E (TTM)
39.4
—
Forward P/E
34.0
7.0
Price/Sales
11.7
8.2
Price/Book
7.5
1.0
EV/EBITDA
33.9
32.7
Dividend Yield
—
—
Profitability
Net Margin
31.40%
-44.60%
Operating Margin
30.00%
-577.00%
Return on Equity
20.20%
-6.66%
Return on Assets
8.86%
-4.18%
Growth (YoY)
Revenue Growth
62.60%
-35.40%
Earnings Growth
114.00%
-43.20%
Price & Risk
Beta
-0.0
1.3
52-Week High
$934.62
$124.00
52-Week Low
$510.06
$79.52
Analyst Target
$1,041.14
$121.59
Compare ARGX and BNTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.